Precision medicine approvals and rare disease treatment incentives evaluated

(Brigham and Women's Hospital) The senior author of two separate articles published in Health Affairs on May 7, Kesselheim, members of the PORTAL research group and co-authors, examine the fast approvals of precision medicines in one paper while evaluating the impact of the Orphan Drug Act's seven-year market exclusivity in the other.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news